無管化與傳統(tǒng)經皮腎鏡的對比研究
發(fā)布時間：2019-07-01 20:36
【摘要】：背景和目的經皮腎鏡技術經過半個多世紀的發(fā)展，在和傳統(tǒng)開放手術的競爭中，逐漸體現(xiàn)出獨特的優(yōu)勢，并成為了復雜性腎結石的首選治療方法。隨著科技的進步，操作水平的提高，近年來不少科學家們逐漸意識到傳統(tǒng)經皮腎鏡術后留置腎造瘺管給患者帶來的痛苦和諸多不便，進而試圖淘汰這種落后的引流方式，并為此做了不少實驗研究工作；但同樣也有不少學者不贊成這種觀點，認為術后不放置腎造瘺管會引起嚴重并發(fā)癥，進而給患者帶來更大的危害。帶著以上兩種觀點，并總結了之前學者們的工作經驗，我們開展了此次臨床對比研究，目的還是為了探討無管化經皮腎鏡相對于傳統(tǒng)經皮腎鏡處理上尿路結石的有效性和安全性，及在臨床工作中是否存在優(yōu)勢。 方法回顧性分析2011年1月-2013年10月期間，105例行經皮腎鏡取石術（percutaneous nephrolithotomy，PCNL）的上尿路結石患者。其中39例行無管化經皮腎鏡取石術（無管化組），另外66例行傳統(tǒng)經皮腎鏡取石術（傳統(tǒng)組）。入選病例在性別、年齡、結石參數(shù)等指標上均無明顯統(tǒng)計學差異（P＞0.05）。對兩組病例的手術時間、術后24h視覺模擬疼痛評分、鎮(zhèn)痛藥需求、感染發(fā)生情況、術后失血情況及輸血率、術后腸道功能恢復時間、腎周血腫及積液情況、術后住院時間、住院費用等指標進行統(tǒng)計分析。 結果105例手術均成功完成，無中轉開放病例，無胸膜及腸管等周圍臟器損傷病例發(fā)生，無感染性休克病例發(fā)生。所有患者出院后均隨訪一月，無嚴重并發(fā)癥出現(xiàn)。無管化組與傳統(tǒng)組在手術時間（52.92±7.95min vs55.59±7.21min P＞0.05），，發(fā)熱發(fā)生率（9/39vs14/66P＞0.05），術后Hb下降值（8.00±4.03g/L vs8.62±4.33g/LP＞0.05），術后HCT下降值（4.29%±1.27%vs4.61%±1.36%P＞0.05），術后輸血率（0/39vs1/66P＞0.05），術后腸道功能恢復時間（15.55±5.59h vs16.74±6.58h P＞0.05），腎周血腫發(fā)生率（2/39vs7/66P＞0.05），腎周積液發(fā)生率（10/39vs28/66P＞0.05）及清石率（33/39vs58/66P＞0.05)方面無明顯統(tǒng)計學差異。而在術后24hVAS（2.41±1.32分vs4.54±1.65分P＜0.05），術后鎮(zhèn)痛藥的需求率（3/39vs15/66P＜0.05），術后恢復工作時間（14.97±4.73d vs20.18±5.25d P＜0.05），術后平均住院時間（5.82±1.00d vs7.76±1.45d P＜0.05），術后平均住院費用（2805.41±385.63元vs4243.86±596.52元P＜0.05）方面均存在明顯統(tǒng)計學差異。 結論無管化經皮腎鏡是對傳統(tǒng)經皮腎鏡手術引流方式的改進，通過臨床對比研究發(fā)現(xiàn)，在減少術后疼痛及鎮(zhèn)痛藥物需求，縮短住院時間、降低醫(yī)療費用等方面具有優(yōu)勢。在經嚴格篩選病例，熟練手術操作和術畢準確判斷能否行無管化的基礎上，無管化經皮腎鏡是一種效果可靠、安全、經濟的方法，值得推廣應用。
[Abstract]:Background and objective after more than half a century of development, percutaneous nephroscopy has gradually shown its unique advantages in the competition with traditional open surgery, and has become the first choice for the treatment of complex kidney stones. With the progress of science and technology and the improvement of operation level, in recent years, many scientists have gradually realized the pain and inconvenience caused by indwelling renostomy tube after traditional transcatheter renal endoscopy, and then tried to eliminate this backward drainage method, and have done a lot of experimental research work for this purpose. However, many scholars do not agree with this view, that the placement of renostomy tube after operation will cause serious complications, and then bring greater harm to patients. With the above two viewpoints and summing up the previous working experience of scholars, we have carried out this clinical comparative study in order to explore the effectiveness and safety of non-tubular percutaneous nephroscopy in the treatment of upper urinary calculi compared with traditional transcatheter nephroscopy, and whether there are advantages in clinical work. Methods from January 2011 to October 2013, 105 patients with upper urinary tract stones treated with percutaneous nephrolithotomy,PCNL were analyzed retrospectively. the results were as follows: (1) from January 2011 to October 2013, 105 patients with upper urinary calculi were analyzed. Among them, 39 cases were treated with non-catheterization and 66 cases with traditional percutaneous nephrolithotomy (traditional group), while 39 cases were treated with endoscophenoscopic lithotomy (non-tubular group) and 66 cases by traditional nephrolithotomy (traditional group), and the other 66 cases were treated with traditional nephrolithotomy. There was no significant difference in sex, age and stone parameters (P > 0.05). The operation time, visual simulated pain score 24 hours after operation, analgesic demand, infection occurrence, postoperative blood loss and transfusion rate, postoperative intestinal function recovery time, perirenal hematomas and fluid accumulation, postoperative hospitalization time and hospitalization expenses were statistically analyzed. Results 105 cases of operation were successfully completed, no cases of conversion to open, no cases of pleura and intestinal tract injury, no cases of septic shock occurred. All patients were followed up for one month after discharge, and no serious complications occurred. The time of operation (52.92 鹵7.95min vs55.59 鹵7.21min P > 0.05), the incidence of fever (9/39vs14/66P > 0.05), the decrease of Hb (8.00 鹵4.03g/L vs8.62 鹵4.33g/LP > 0.05), the decrease of HCT (4.29% 鹵1.27% vs 4.61% 鹵1.36% P > 0.05), the postoperative transfusion rate (0/39vs1/66P > 0.05). There was no significant difference in the recovery time of intestinal function (15.55 鹵5.59h vs16.74 鹵6.58h P > 0.05), the incidence of perirenal hematomas (2/39vs7/66P > 0.05), the incidence of perirenal fluid accumulation (10/39vs28/66P > 0.05) and the rate of stone clearance (33/39vs58/66P > 0.05). The postoperative 24hVAS (2.41 鹵1.32 vs4.54 鹵1.65, P < 0.05), the demand rate of postoperative painkillers (3/39vs15/66P < 0.05), the recovery time (14.97 鹵4.73 d vs20.18 鹵5.25 d P < 0.05), and the average postoperative hospital stay (5.82 鹵1.00 d vs7.76 鹵1.45 d P < 0.05), the postoperative recovery time (14.97 鹵4.73 d vs20.18 鹵5.25 d P < 0.05), the average postoperative hospital stay (5.82 鹵1.00 d vs7.76 鹵1.45 d P < 0.05). There were significant differences in the average postoperative hospitalization expenses (2805.41 鹵385.63 yuan vs4243.86 鹵596.52 yuan, P < 0.05). Conclusion Catheter is an improvement of traditional endoscopic drainage. Through clinical comparative study, it is found that it has advantages in reducing postoperative pain and analgesic drug demand, shortening hospitalization time and reducing medical expenses. On the basis of strict screening of cases, skillful operation and accurate judgment of tracheization at the end of operation, tubular percutaneous nephroscopy is a reliable, safe and economical method, which is worth popularizing and applying.
【學位授予單位】：安徽醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：R699.2
本文編號：2508775
[Abstract]:Background and objective after more than half a century of development, percutaneous nephroscopy has gradually shown its unique advantages in the competition with traditional open surgery, and has become the first choice for the treatment of complex kidney stones. With the progress of science and technology and the improvement of operation level, in recent years, many scientists have gradually realized the pain and inconvenience caused by indwelling renostomy tube after traditional transcatheter renal endoscopy, and then tried to eliminate this backward drainage method, and have done a lot of experimental research work for this purpose. However, many scholars do not agree with this view, that the placement of renostomy tube after operation will cause serious complications, and then bring greater harm to patients. With the above two viewpoints and summing up the previous working experience of scholars, we have carried out this clinical comparative study in order to explore the effectiveness and safety of non-tubular percutaneous nephroscopy in the treatment of upper urinary calculi compared with traditional transcatheter nephroscopy, and whether there are advantages in clinical work. Methods from January 2011 to October 2013, 105 patients with upper urinary tract stones treated with percutaneous nephrolithotomy,PCNL were analyzed retrospectively. the results were as follows: (1) from January 2011 to October 2013, 105 patients with upper urinary calculi were analyzed. Among them, 39 cases were treated with non-catheterization and 66 cases with traditional percutaneous nephrolithotomy (traditional group), while 39 cases were treated with endoscophenoscopic lithotomy (non-tubular group) and 66 cases by traditional nephrolithotomy (traditional group), and the other 66 cases were treated with traditional nephrolithotomy. There was no significant difference in sex, age and stone parameters (P > 0.05). The operation time, visual simulated pain score 24 hours after operation, analgesic demand, infection occurrence, postoperative blood loss and transfusion rate, postoperative intestinal function recovery time, perirenal hematomas and fluid accumulation, postoperative hospitalization time and hospitalization expenses were statistically analyzed. Results 105 cases of operation were successfully completed, no cases of conversion to open, no cases of pleura and intestinal tract injury, no cases of septic shock occurred. All patients were followed up for one month after discharge, and no serious complications occurred. The time of operation (52.92 鹵7.95min vs55.59 鹵7.21min P > 0.05), the incidence of fever (9/39vs14/66P > 0.05), the decrease of Hb (8.00 鹵4.03g/L vs8.62 鹵4.33g/LP > 0.05), the decrease of HCT (4.29% 鹵1.27% vs 4.61% 鹵1.36% P > 0.05), the postoperative transfusion rate (0/39vs1/66P > 0.05). There was no significant difference in the recovery time of intestinal function (15.55 鹵5.59h vs16.74 鹵6.58h P > 0.05), the incidence of perirenal hematomas (2/39vs7/66P > 0.05), the incidence of perirenal fluid accumulation (10/39vs28/66P > 0.05) and the rate of stone clearance (33/39vs58/66P > 0.05). The postoperative 24hVAS (2.41 鹵1.32 vs4.54 鹵1.65, P < 0.05), the demand rate of postoperative painkillers (3/39vs15/66P < 0.05), the recovery time (14.97 鹵4.73 d vs20.18 鹵5.25 d P < 0.05), and the average postoperative hospital stay (5.82 鹵1.00 d vs7.76 鹵1.45 d P < 0.05), the postoperative recovery time (14.97 鹵4.73 d vs20.18 鹵5.25 d P < 0.05), the average postoperative hospital stay (5.82 鹵1.00 d vs7.76 鹵1.45 d P < 0.05). There were significant differences in the average postoperative hospitalization expenses (2805.41 鹵385.63 yuan vs4243.86 鹵596.52 yuan, P < 0.05). Conclusion Catheter is an improvement of traditional endoscopic drainage. Through clinical comparative study, it is found that it has advantages in reducing postoperative pain and analgesic drug demand, shortening hospitalization time and reducing medical expenses. On the basis of strict screening of cases, skillful operation and accurate judgment of tracheization at the end of operation, tubular percutaneous nephroscopy is a reliable, safe and economical method, which is worth popularizing and applying.
【學位授予單位】：安徽醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：R699.2
【參考文獻】
相關期刊論文 前10條
1 熊六林;葉雄俊;馬凱;黃曉波;王曉峰;;無管化24F通道經皮腎鏡治療腎輸尿管上段結石的初步探討[J];北京大學學報(醫(yī)學版);2013年04期
2 陳衛(wèi)紅;單剛;王元林;劉軍;孫兆林;朱建國;;α_1受體阻滯劑在經皮腎鏡術后的應用[J];臨床泌尿外科雜志;2011年12期
3 羅勇;王洛夫;李家寬;蘭衛(wèi)華;萬江華;葛成國;畢罡;李彥鋒;江軍;靳風爍;;無管化經皮腎鏡取石術的安全性和療效評價[J];臨床泌尿外科雜志;2012年03期
4 陳云濤;李立;汪自力;楊進;;經皮腎鏡取石術后嚴重出血的動脈栓塞治療[J];華西醫(yī)學;2013年02期
5 邵和平;盧奕進;顧思平;許玉龍;黎德玉;;超聲引導下經皮腎鏡取石術的臨床研究[J];臨床超聲醫(yī)學雜志;2013年06期
6 畢革文;;經皮腎鏡治療腎及輸尿管上段結石的研究進展[J];微創(chuàng)醫(yī)學;2012年03期
7 戚德峰,吳開俊,李遜,單幟昌,夏民義,郭彬,陳文忠,曾國華;輸尿管內支架對人腎盂及膀胱壓影響的研究[J];現(xiàn)代臨床醫(yī)學生物工程學雜志;2003年03期
8 孫穎浩;高小峰;;鈥激光在泌尿外科中的應用[J];醫(yī)學研究雜志;2010年08期
9 曹正國;吳斌;諸禹平;蘇紅;孫友文;董曉程;朱明;;一期多通道微創(chuàng)經皮腎鏡鈥激光碎石和單通道經皮腎鏡碎石治療鹿角形腎結石的對照研究[J];中國內鏡雜志;2008年09期
10 鄒曉峰,黃明,李遜,袁源湖,肖日海,李旺林,羅道升,肖運政,伍耿青;經皮腎微造瘺輸尿管鏡取石術治療上尿路結石[J];中華泌尿外科雜志;2003年10期
本文編號：2508775
本文鏈接：http://sikaile.net/yixuelunwen/mjlw/2508775.html
最近更新
教材專著
